Daye peak "unsealed" after the market
Release time:
2020-07-22
Daye Peak "Unsealing " After the market
News The new coronary pneumonia epidemic has had a huge impact on all walks of life and people's lives, and the established work arrangements of Daye Peak Cement Company, which is located in the hardest hit area of the epidemic, have all been disrupted. In order to grab the market and reduce the losses caused by the epidemic, Daye Peak Marketing Department actively responded by laying out in advance, grabbing the market after "unsealing " , and the market gradually began to recover. 3 June 18 , Daye Peak resumed market supply of cement products.
As the epidemic pressure slows down, Hubei Province gradually "unsealed " . However, when Daye peak sales resumed, the market situation was not optimistic. The surrounding counties and cities had not been unsealed, traffic was seriously blocked, the project start-up rate was low, the market demand was small, the clinker was full of stock, the technical transformation and maintenance of the production line were nearing the end, and the balance of the end of the pressure after the production. For this reason, daye peak marketing department actively took countermeasures and laid out the layout in advance. in view of the demand for bagged market, but the traffic control in the city and the impassability of trucks, daye city economic and information bureau actively communicated with daye city economic and information bureau to help customers handle the pass and ensure the normal delivery of bagged cement. At the same time, in order to reduce the risk of full storage after the resumption of production and actively and rapidly expand clinker sales, the marketing department organized all capable marketers to visit nearby county and city grinding stations in division of labor to understand the clinker demand and inventory situation of the grinding stations and successfully start clinker sales. By 4 July 10 , a total of more than 2 tons of clinker had been sold, enabling raw materials to enter the factory as planned and reducing production pressure.
Wuhan has been a key market for Daye Peak, and due to the late start of the epidemic, the impact on cement output is very large. To this end, the marketing department organized all marketers to sink to the front line of the market to understand the end customer's resumption of production and cement demand, and actively take measures to expand the volume. At the same time, while actively maintaining the original customers, we will vigorously develop new customers in Huangshi, Xianning, Huanggang and other regions, and make up for the lack of overall sales by increasing the sales volume in these regions.
With the increasing rate of engineering resumption in Hubei Province, the Wuhan market is also gradually starting, Daye peak daily sales continue to improve, gradually returning to the normal level of previous years. ( Jing Fangzheng Li Jun )
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page